Support Us — Your donation helps us keep running

Goal: 1000 CNY,Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2017-1290
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
IBM OpenPages GRC Platform 7.1, 7.2, and 7.3 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 125151.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
IBM OpenPages GRC Platform 跨站脚本漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
IBM OpenPages GRC Platform是美国IBM公司的一套用于管理企业风险和合规性的平台。该平台提供一组涵盖风险和合规性领域(包括操作风险、策略和合规性、财务控制管理等)的核心服务和功能组件。 IBM OpenPages GRC Platform 7.1版本、7.2版本和7.3版本中存在跨站脚本漏洞。远程攻击者可利用该漏洞向Web UI注入任意的JavaScript代码。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
IBMOpenPages GRC Platform 7.1 -
II. Public POCs for CVE-2017-1290
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2017-1290
Please Login to view more intelligence information
New Vulnerabilities
V. Comments for CVE-2017-1290

No comments yet


Leave a comment